New Delhi – Air India announced mandatory drug and illegal substance screening for all flight crew members, moving beyond the regulatory requirement of 10% annual random testing. Consequently, this decisive policy enforcement highlights the airline’s commitment to overhauling operational safety and restoring passenger confidence.
Furthermore, the decision directly follows an August 4 safety incident involving an Airbus A320 traveling from Phuket to New Delhi, which suddenly dropped 91 meters shortly after takeoff, injuring 24 passengers. As a result, the carrier instituted immediate mandatory testing across its entire pilot roster.
Multi-Agency Investigations and Corporate Restructuring
On the other hand, the French Civil Aviation Safety Investigation and Analysis Bureau (BEA) alongside Airbus engineers are investigating the technical and human factors surrounding the flight, amidst media reports concerning pilot impairment. Additionally, the airline is undergoing leadership changes, having recently appointed former Ethiopian Airlines chief Tewolde GebreMariam as CEO.
Consequently, strict substance protocols and management restructuring aim to mitigate operational risks and enforce compliance across all flight operations. Ultimately, these measures serve to rebuild brand integrity following previous safety challenges.
Finally, Air India’s universal testing mandate reflects a proactive shift toward stringent safety management. Ultimately, transparent investigative findings and strict regulatory adherence will dictate the airline’s operational recovery.
